Feed CASIF
CA

CASI Pharmaceuticals, Inc.

CASIF · OTC

$0.13 -4.59% (-$0.01)
1M +0.00%
Market Cap $2.65M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.13x
PEG N/A
P/B N/A
Growth
9 /100
Declining
Book val. growth 72.02%
Rev. growth 1.84%
FCF growth N/A
Profitability
22 /100
Weak
Net margin 218.55%
Op. margin 190.98%
FCF margin 0.00%
Quality
74 /100
Excellent
ROA 208.70%
Asset turnover 0.95x
ROIC 759.62%
Debt
0 /100
High
Int. coverage -100.15x
Current ratio 0.15x
Net debt/EBITDA N/A
Stability
35 /100
Moderate
Rev. volatility 35.61%
EPS volatility 31.04%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CASIF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

David A. Cory

Employees

214

Headquarters

Beijing

Upcoming events

25 SEP

Earnings

Upcoming earnings report

4d
13 NOV

Earnings

Upcoming earnings report

53d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.